Sodium control in aneurysmal subarachnoid haemorrhage

• Conditions: Hyponatraemia in subarachnoid haemorrhage; Metabolic and Endocrine - Other metabolic disorders; Stroke - Haemorrhagic

• Registration Number: ACTRN12613000999730
• Lead Sponsor: Dr Stephanie Teasdale

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-09-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

Inclusion:
*D1-18 aneurysmal SAH
*Serum Na <135mmol/L

Exclusion Criteria

Exclusion:
*Thyroid abnormality
*Cortisol abnormality
*Pre-morbid cardiopulmonary disease
*Pre-morbid electrolyte imbalance
*Pre-morbid treated hypertension
*Pre-morbid systemic fungal infection
*Women who are pregnant
*Children and/or young people (<18 years)
*Aged (>80 years)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sodium nadir by twice daily serum electrolytes[Day 1-18 post aneurysmal subarachnoid haemorrhage]

Secondary Outcome Measures

Name	Time	Method
Duration sodium <135mmol/L according to twice daily serum electrolytes[Day 1-18 post subarachnoid haemorrhage];Duration and intensity of oral fluid restriction, according to mL oral fluid consumed daily[Day 1-18 post aneurysmal subarachnoid haemorrhage];Duration and intensity of hypertonic saline delivery, according to mL hypertonic saline delivered daily[Day 1-18 post subarachnoid haemorrhage]